Deals Of The Week: Qiagen/DxS; LEO/Warner Chilcott; Nektar/AstraZeneca ...
Executive Summary
Each week, "The Pink Sheet" presents commentary on some of the week's most interesting business deals, contributed by the editors of the IN VIVO blog. Visit the blog at 1http://invivoblog.blogspot.com/.
You may also be interested in...
LEO Pharma Pays $1 Billion To Get Its Psoriasis Drugs Back From Warner Chilcott
American dermatology dream: Danish specialty pharma plans to establish beachhead up in New Jersey after buying back U.S. rights.
Nektar Dips Into AstraZeneca's Deep Pockets With OIC Deal
As Nektar reinvents itself, the specialty drug developer gets multi-million dollar validation from AstraZeneca in deal for NKTR-118.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011